• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者脑脊液中酪氨酸、L-二羟基苯丙氨酸、多巴胺和3-O-甲基多巴的浓度。

Concentrations of tyrosine, L-dihydroxyphenylalanine, dopamine, and 3-O-methyldopa in the cerebrospinal fluid of Parkinson's disease.

作者信息

Tohgi H, Abe T, Takahashi S, Nozaki Y, Kikuchi T

机构信息

Department of Neurology, Iwate Medical University, Morioka, Japan.

出版信息

Neurosci Lett. 1991 Jun 24;127(2):212-4. doi: 10.1016/0304-3940(91)90796-v.

DOI:10.1016/0304-3940(91)90796-v
PMID:1908962
Abstract

We determined the concentrations of tyrosine, L-3,4-dihydroxyphenylalanine (DOPA), dopamine (DA), and 3-O-methyldopa (3-OMD) in the cerebrospinal fluid (CSF) of parkinsonian patients and elevated potential interactions between the substances. We found a significant increase in tyrosine, and a significant decrease in DOPA, DA, and 3-OMD. We also found that for a given concentration of DOPA, DA and 3-OMD were proportional. In addition, the ratio of DA to 3-OMD was significantly shifted in favor of DA in parkinsonian patients.

摘要

我们测定了帕金森病患者脑脊液(CSF)中酪氨酸、L-3,4-二羟基苯丙氨酸(多巴)、多巴胺(DA)和3-O-甲基多巴(3-OMD)的浓度,并研究了这些物质之间可能存在的相互作用增强情况。我们发现酪氨酸显著增加,而多巴、多巴胺和3-OMD显著减少。我们还发现,在给定的多巴浓度下,多巴胺和3-OMD呈比例关系。此外,帕金森病患者中多巴胺与3-OMD的比例明显向有利于多巴胺的方向偏移。

相似文献

1
Concentrations of tyrosine, L-dihydroxyphenylalanine, dopamine, and 3-O-methyldopa in the cerebrospinal fluid of Parkinson's disease.帕金森病患者脑脊液中酪氨酸、L-二羟基苯丙氨酸、多巴胺和3-O-甲基多巴的浓度。
Neurosci Lett. 1991 Jun 24;127(2):212-4. doi: 10.1016/0304-3940(91)90796-v.
2
The significance of 3-O-methyldopa concentrations in the cerebrospinal fluid in the pathogenesis of wearing-off phenomenon in Parkinson's disease.
Neurosci Lett. 1991 Oct 28;132(1):19-22. doi: 10.1016/0304-3940(91)90422-p.
3
CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.帕金森病患者脑脊液和血浆中游离去甲肾上腺素、多巴胺、3,4-二羟基苯乙酸(DOPAC)、3,4-二羟基苯丙氨酸(DOPA)及肾上腺素的浓度
Acta Neurol Scand. 1995 Aug;92(2):116-21. doi: 10.1111/j.1600-0404.1995.tb01023.x.
4
Effects of the catechol-O-methyltransferase inhibitor tolcapone in Parkinson's disease: correlations between concentrations of dopaminergic substances in the plasma and cerebrospinal fluid and clinical improvement.
Neurosci Lett. 1995 Jun 16;192(3):165-8. doi: 10.1016/0304-3940(95)11636-b.
5
Effects of 3-O-methyldopa, L-3,4-dihydroxyphenylalanine metabolite, on locomotor activity and dopamine turnover in rats.3-O-甲基多巴(L-3,4-二羟基苯丙氨酸代谢产物)对大鼠运动活动和多巴胺周转率的影响。
Biol Pharm Bull. 2012;35(8):1244-8. doi: 10.1248/bpb.b110714.
6
Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L-3,4-dihydroxyphenylalanine (L-dopa).
Neurology. 1971 May;21(5):540-9. doi: 10.1212/wnl.21.5.540.
7
Concentration of catecholamines and indoleamines in the cerebrospinal fluid of patients with vascular parkinsonism compared to Parkinson's disease patients.与帕金森病患者相比,血管性帕金森病患者脑脊液中儿茶酚胺和吲哚胺的浓度。
J Neural Transm (Vienna). 1997;104(4-5):441-9. doi: 10.1007/BF01277662.
8
Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis.未经治疗的不宁腿综合征(RLS)患者脑脊液中3-邻甲基多巴(3-OMD)异常增加表明病情更严重,且可能存在多巴胺合成异常增加的情况。
Sleep Med. 2009 Jan;10(1):123-8. doi: 10.1016/j.sleep.2007.11.012. Epub 2008 Jan 28.
9
A new method for the determination of L-dopa and 3-O-methyldopa in plasma and cerebrospinal fluid using gas chromatography and electron capture negative ion mass spectrometry.一种使用气相色谱法和电子捕获负离子质谱法测定血浆和脑脊液中左旋多巴和3 - O - 甲基多巴的新方法。
Clin Chim Acta. 1988 Jan 15;171(1):49-61. doi: 10.1016/0009-8981(88)90290-2.
10
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.帕金森病患者脑脊液中儿茶酚胺及其代谢产物水平:左旋多巴治疗的影响及左旋多巴诱发异动症的变化
J Neurochem. 2017 May;141(4):614-625. doi: 10.1111/jnc.13997. Epub 2017 Mar 30.

引用本文的文献

1
The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson's Disease Patients.代谢组学方法揭示帕金森病患者血清和脑脊液成分的改变。
Pharmaceuticals (Basel). 2021 Sep 17;14(9):935. doi: 10.3390/ph14090935.
2
Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.帕金森病患者的脑脊液生化研究:寻找这种疾病潜在生物标志物的方法。
Front Cell Neurosci. 2014 Nov 11;8:369. doi: 10.3389/fncel.2014.00369. eCollection 2014.
3
The role of 3-O-methyldopa in the side effects of L-dopa.
3 - O - 甲基多巴在左旋多巴副作用中的作用。
Neurochem Res. 2008 Mar;33(3):401-11. doi: 10.1007/s11064-007-9442-6. Epub 2007 Aug 24.
4
Concentration of catecholamines and indoleamines in the cerebrospinal fluid of patients with vascular parkinsonism compared to Parkinson's disease patients.与帕金森病患者相比,血管性帕金森病患者脑脊液中儿茶酚胺和吲哚胺的浓度。
J Neural Transm (Vienna). 1997;104(4-5):441-9. doi: 10.1007/BF01277662.